Nova Medical Centers is Now Offering
Onsite COVID-19 Saliva Testing

Nova Medical Centers is dedicated to protecting your employees and worksites as the economy starts to open by offering on-site COVID-19 saliva testing.

Why Should Your Company Test?

  • Security for your employees
  • Protect your business and avoid possible shutdown
  • Understanding the current state of exposure to your company
  • Ability to plan for returning workers
  • Reduce exposure to unaffected workforce
  • Maintain/Improve productivity
  • Planning for future waves of infections
  • Practical/Non-invasive
  • Test and result large populations quickly
  • Helps control the spread of COVID-19 for larger society

CDC Guidance


SARS-CoV-2 Testing Strategy: Considerations for Non-Healthcare Workplaces

Public health surveillance for SARS-CoV-2 testing is considered to be surveillance when conducted to detect transmission hot spots, or to better understand disease trends in the workplace.  These goals are consistent with employer-based occupational medicine surveillance programs. Occupational medicine surveillance programs may use testing to assess the burden of SARS-CoV-2 in the workforce, assess factors that place employees at risk for workplace acquisition of SARS-CoV-2, or evaluate the effectiveness of workplace infection control programs. Surveillance should only be undertaken if the results have a reasonable likelihood of benefiting workers.

What Type of COVID-19 Test Are You Getting?

*Result turnaround time is from when the lab receives the sample.

About the COVID-19 Saliva Test

  • FDA Emergency Use Authorization – (EUA)
    • After meeting clinical testing requirements, the FDA issued an EUA to distribute and use the COVID-19 Saliva test on 5/7/2020 to Rutgers Clinical Genomics Laboratory (RCGL)
    • Tests made available under an EUA have not undergone the same type of review as an FDA-approved or cleared test. FDA may issue an EUA when certain criteria are met, which includes that there are no adequate, approved, or available alternatives, and based on the totality of scientific evidence available, it is reasonable to believe that the test may be effective.
  • Yale University Study
    • Independent study by Yale University, published on 4/22/2020
    • Showed saliva testing to be more sensitive than nasopharyngeal swabbed tests.
  • The RCGL saliva test is designed to detect RNA in the SARS-CoV-2 virus which causes COVID-19
    • DO NOT eat, drink, smoke or chew gum 30 minutes prior to collection
    • Collection chemistry inactivates 100% of the live virus while preserving the RNA for detection on testing
    • The RCGL test has a small chance of producing an inconclusive result. (Relative Sensitivity /True Positive Rate: 100%, Relative Specificity/True Negative Rate: 100%, Overall Accuracy: 99%) EUA w/ Clinical Data
    • Retesting by your PCP may be recommended, if test is positive, inconclusive or negative with symptoms

FDA Patient Factsheet

What Do The Results Mean?

Positive Negative Inconclusive*
Am I infected? YES NO POSSIBLY
Can I infect others? YES NO POSSIBLY
Should I consider getting another test if I DON’T have symptoms? NO NO YES
Should I consider getting another test if I DO have symptoms? NO YES YES
•An inconclusive test result means that the test could not definitively determine whether you are infected with the SARS-CoV-2 virus.

•Only in 2% of cases are test results inconclusive.

How Can I Best Protect my Employees and Company?

  • Establish baseline – Initial onsite COVID-19 saliva testing for your worksite
  • Periodic Testing – Repeat onsite COVID-19 saliva testing for your worksite (1 every 2-3 weeks)
  • Daily temperature checks at the beginning of each shift to identify symptomatic employees outside of testing windows
  • Positives for any of the above referred to employees PCP for further evaluation, treatment and/or return to work clearance

How can Nova Medical Centers help?

Please Note: Global demand for COVID-19 testing is extremely high and supplies are very limited.

Timing is critical to secure testing for your employees and worksite.

Sign up TODAY! Quantities are limited and first-come, first-serve.

Just fill out the form on this page or contact your Nova Industrial Director.

Please note:  Onsite Rapid COVID-19 Saliva Testing requires a minimum of 20 tests per session

Additional Education Resources on the COVID-19 Saliva Test:

For Information:



Yale School of Medicine

First FDA EUA Authorized COVID-19 Saliva Test